A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD
NCT ID: NCT00280371
Last Updated: 2010-11-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
345 participants
INTERVENTIONAL
2006-01-31
2007-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Formoterol Fumarate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current or prior history of cigarette smoking
Exclusion Criteria
* Chest X-ray diagnostic of significant disease other than COPD
* Significant condition or disease other than COPD
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dey
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dey
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Jasper, Alabama, United States
Research Site
Phoenix, Arizona, United States
Research Site
Buena Park, California, United States
Research Site
Costa Mesa, California, United States
Research Site
Huntington Beach, California, United States
Research Site
Long Beach, California, United States
Research Site
San Diego, California, United States
Research Site
Stockton, California, United States
Research Site
Walnut Creek, California, United States
Research Site
Denver, Colorado, United States
Research Site
Wheat Ridge, Colorado, United States
Research Site
Clearwater, Florida, United States
Research Site
DeLand, Florida, United States
Research Site
Miami Beach, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
Atlanta, Georgia, United States
Research Site
Coeur d'Alene, Idaho, United States
Research Site
Hines, Illinois, United States
Research Site
Normal, Illinois, United States
Research Site
Overland Park, Kansas, United States
Research Site
Shawnee Mission, Kansas, United States
Research Site
Topeka, Kansas, United States
Research Site
North Dartmouth, Massachusetts, United States
Research Site
Minneapolis, Minnesota, United States
Research Site
Rochester, Minnesota, United States
Research Site
St Louis, Missouri, United States
Research Site
St Louis, Missouri, United States
Research Site
Henderson, Nevada, United States
Research Site
Summit, New Jersey, United States
Research Site
Camillus, New York, United States
Research Site
Asheville, North Carolina, United States
Research Site
Charlotte, North Carolina, United States
Research Site
Elizabeth City, North Carolina, United States
Research Site
Raleigh, North Carolina, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Oklahoma City, Oklahoma, United States
Research Site
Medford, Oregon, United States
Research Site
Portland, Oregon, United States
Research Site
Upland, Pennsylvania, United States
Research Site
Cranston, Rhode Island, United States
Research Site
Spartanburg, South Carolina, United States
Research Site
Austin, Texas, United States
Research Site
Dallas, Texas, United States
Research Site
Houston, Texas, United States
Research Site
Waco, Texas, United States
Research Site
South Burlington, Vermont, United States
Research Site
Abingdon, Virginia, United States
Research Site
Richmond, Virginia, United States
Research Site
Tacoma, Washington, United States
Research Site
Madison, Wisconsin, United States
Research Site
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201-069
Identifier Type: -
Identifier Source: org_study_id